所见非所得:分子放疗中基于体素的剂量学准确性研究
该研究用3D打印双腔肾脏体模进行177Lu SPECT/CT的体素级剂量学计算,比较不同重建参数及PETPVC部分容积校正的效果;结果显示SPECT/CT成像将两个子器官的离散吸收剂量值模糊为连续分布,即使经PETPVC校正后仍与名义值存在明显差异,作者因此对基于SPECT的体素级剂量学可靠性提出质疑。
要点
- SPECT/CT成像将肾脏皮质与髓质两个离散吸收剂量值模糊为连续分布。
- 增加迭代次数可轻微改善该效应,而额外的后滤波会增强该效应。
- 应用PETPVC后剂量分布分为两个峰,与名义值一致性改善但仍存在明显差异。
核心结论
- 177Lu定量SPECT/CT成像得到的体素级剂量分布与真实器官分布差异很大,SPECT/CT成像与重建缺陷可能直接转化为不现实的吸收剂量分布,从而质疑基于SPECT的体素级剂量学的可靠性。
- 作者认为SPECT/CT重建应加以调整,以确保对预期大小物体(如器官、器官亚结构、病灶或体素)感兴趣区内 underlying 活度及吸收剂量进行准确定量。
- 作者认为体素级剂量学的概念应谨慎对待,尤其应记住吸收剂量分布主要是 underlying SPECT重建的卷积版本。
研究设计与样本
- 对3D打印双腔肾脏体模(70%皮质、30%髓质)进行SPECT/CT的体素级剂量学计算,两腔填充不同活度浓度。
- 图像采用不同设置(迭代次数、子集数、后滤波)重建,基于活度浓度图用预先计算的177Lu体素S值和经验肾脏半衰期计算吸收剂量分布。
- 另计算一组在应用PETPVC对SPECT重建进行部分容积校正后的吸收剂量。
主要发现
- SPECT/CT成像将两个离散的子器官吸收剂量值模糊为连续分布,该效应经更多迭代次数略有改善,但被额外后滤波增强。
- 应用PETPVC后吸收剂量值分离为两个峰,使基于SPECT/CT的值与名义值一致性更好,但仍存在明显差异。
- 计算的名义吸收剂量为皮质7.8 Gy、髓质1.6 Gy,而基于SPECT/CT的体素级剂量学所得平均吸收剂量为皮质3.0–6.6 Gy、髓质2.7–5.1 Gy。
- PETPVC使范围改善为皮质6.1–8.9 Gy、髓质2.1–5.4 Gy。
关键数值与推荐
- 名义吸收剂量:皮质7.8 Gy,髓质1.6 Gy。
- 基于SPECT/CT的体素级剂量学平均吸收剂量:皮质3.0–6.6 Gy,髓质2.7–5.1 Gy。
- 应用PETPVC后的吸收剂量范围:皮质6.1–8.9 Gy,髓质2.1–5.4 Gy。
临床怎么用
- 作者认为SPECT/CT重建应加以调整,以确保对预期大小物体(如器官、器官亚结构、病灶或体素)感兴趣区内 underlying 活度及吸收剂量进行准确定量。
- 作者以PETPVC为例指出其可大幅改善基于SPECT/CT与名义剂量分布之间的一致性。
- 作者认为体素级剂量学的概念应谨慎对待,应记住吸收剂量分布主要是 underlying SPECT重建的卷积版本。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Improvements in quantitative SPECT/CT have aroused growing interest in voxel-based dosimetry for radionuclide therapies, because it promises visualization of absorbed doses at a voxel level. In this work, SPECT/CT-based voxel-level dosimetry of a 3-dimensional (3D) printed 2-compartment kidney phantom was performed, and the resulting absorbed dose distributions were examined. Additionally, the potential of the PETPVC partial-volume correction tool was investigated. Methods: Both kidney compartments (70% cortex, 30% medulla) were filled with different activity concentrations, and SPECT/CT imaging was performed. The images were reconstructed using varying settings (iterations, subsets, and postfiltering). On the basis of these activity concentration maps, absorbed dose distributions were calculated with precalculated 177Lu voxel S values and an empiric kidney half-life. An additional set of absorbed doses was calculated after applying PETPVC for partial-volume correction of the SPECT reconstructions. Results: SPECT/CT imaging blurs the 2 discrete suborgan absorbed dose values into a continuous distribution. Although this effect is slightly improved by applying more iterations, it is enhanced by additional postfiltering. By applying PETPVC, the absorbed dose values are separated into 2 peaks. Although this leads to a better agreement between SPECT/CT-based and nominal values, considerable discrepancies remain. In contrast to the calculated nominal absorbed doses of 7.8 and 1.6 Gy (in the cortex and medulla, respectively), SPECT/CT-based voxel-level dosimetry resulted in mean absorbed doses of 3.0-6.6 Gy (cortex) and 2.7-5.1 Gy (medulla). PETPVC led to improved ranges of 6.1-8.9 Gy (cortex) and 2.1-5.4 Gy (medulla). Conclusion: Our study showed that 177Lu quantitative SPECT/CT imaging leads to voxel-based dose distributions largely differing from the real organ distribution. SPECT/CT imaging and reconstruction deficiencies might directly translate into unrealistic absorbed dose distributions, thus questioning the reliability of SPECT-based voxel-level dosimetry. Therefore, SPECT/CT reconstructions should be adapted to ensure an accurate quantification of the underlying activity and, therefore, absorbed dose in a volume of interest of the expected object size (e.g., organs, organ substructures, lesions, or voxels). As an example, PETPVC largely improves the match between SPECT/CT-based and nominal dose distributions. In conclusion, the concept of voxel-based dosimetry should be treated with caution. Specifically, one should remember that the absorbed dose distribution is mainly a convolved version of the underlying SPECT reconstruction.
引用
- Tran-Gia J, Salas-Ramirez M, Lassmann M, et al. What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular Radiotherapy. J Nucl Med. 2019. PMID: 31862802. doi:10.2967/jnumed.119.231480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。